Business, energy, technology, markets and global industry news from Business News Today

dry powder inhaler

Medical Devices & Diagnostics

Phillips Medisize targets formulation-device risk as inhaled therapies grow more complex

Inhalers are getting smarter, but complexity can backfire. Phillips Medisize is betting DPI success starts with patient-centric design.

Read More
Medical Devices & Diagnostics

AptarGroup enters Phase II POSITS study as delivery partner for ENA Respiratory’s INNA-051 nasal spray

Aptar's UDS Powder system enters ENA Respiratory's POSITS Phase II trial. Analyse what INNA-051 must prove in 2026 and why the device choice matters. Read more.

Read More
Pharma & Biotech

Aptar Pharma and COVIRIX Medical partner to develop inhaled broad-spectrum antiviral treatment

Aptar Pharma and COVIRIX Medical announce a DPI feasibility collaboration for inhaled broad-spectrum antivirals. Read the analysis.

Read More
Pharma & Biotech

How Kenox Pharmaceuticals is targeting the OINDP CDMO gap with integrated clinical manufacturing

Kenox Pharmaceuticals announces clinical manufacturing readiness for inhaled and nasal drug products. What this means for OINDP development timelines and IVBE strategy.

Read More
Pharma & Biotech

Can Kinaset’s inhaled JAK inhibitor finally bring relief to all severe asthma patients?

Kinaset raises $103M to advance frevecitinib, a novel inhaled JAK inhibitor for severe asthma. Find out what makes this candidate different.

Read More